本页面由Tiger Trade Technology Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.95
0.0000
成交量:1.54万
成交额:3.00万
市值:591.14万
市盈率:0.00
高:2.00
开:1.91
低:1.91
收:1.95
52周最高:12.30
52周最低:1.90
股本:303.15万
流通股本:214.25万
量比:0.80
换手率:0.72%
股息:- -
股息率:- -
每股收益(TTM):-977.1003
每股收益(LYR):-1,791.0249
净资产收益率:-211.37%
总资产收益率:-77.12%
市净率:1.22
市盈率(LYR):0.00

数据加载中...

2019/10/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/10/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/11

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/08

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/12

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers